Precipio, Inc. (NASDAQ:PRPO) Short Interest Update

Precipio, Inc. (NASDAQ:PRPO) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totalling 2,700 shares, a decline of 15.6% from the December 15th total of 3,200 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 7,100 shares, the days-to-cover ratio is presently 0.4 days.

Precipio Trading Up 0.8 %

Shares of NASDAQ:PRPO opened at $6.15 on Friday. The business’s 50 day moving average price is $5.86 and its 200-day moving average price is $5.93. Precipio has a 1 year low of $4.31 and a 1 year high of $7.30. The company has a current ratio of 0.73, a quick ratio of 0.60 and a debt-to-equity ratio of 0.02.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.